| ActRIIA | type IIA activin receptorv |
| ActRIIB | activin type IIB receptor |
| ALK4/5 | activin receptor-like kinase 4 or 5 |
| AMPK | 5’AMP-activated protein kinase |
| AngII | angiotensin II |
| AT1R | angiotensin II type I receptor |
| BHD | bicarbonate hemodialysis |
| BMP1 | bone morphogenic protein 1 |
| BMP-11 | bone morphogenetic protein 11 |
| COPD | chronic obstructive pulmonary disease |
| CRP | C-reactive protein |
| DF-3 | follistatin-derived myostatin inhibitory peptide |
| EHC | euglycemic-hyperinsulinemic clamp |
| ELISA | enzyme-linked immunosorbent assay |
| EWGSOP | European Working Group in Sarcopenia in Older People |
| FLRG | follistatin–related gene |
| FNDC5 | fibronectin type III domain-containing protein 5 |
| FoxO | forkhead box protein O |
| GASP-1 | growth and serum protein-1 |
| GDF-8 | growth differentiation factor -8 |
| GDF-11 | growth differentiation factor 11 |
| HD | hemodialysis |
| HDF | hemodiafiltration |
| HF | heart failure |
| HOMA-IR | Homeostatic Model Assessment for Insulin Resistance |
| IL-6 | interleukin 6 |
| IL-15 | interleukin 15 |
| IGF-1 | insulin-like growth factor |
| MEF2 | myocyte-specific enhancer factor |
| miRNA | micro RNA |
| MRF4 | myogenic regulatory factor 4 |
| mTOR | mammalian target of rapamycin |
| mTORC1 | mammalian target of rapamycin complex 1 |
| MYF5 | myogenic factor 5 |
| MYF6 | myogenic factor 6 |
| MyoD | myoblast determination protein 1 |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NT-proBNP | N-terminal pro B-type natriuretic peptide |
| PPARγ | peroxisome proliferator-activated receptor gamma |
| p38MAPK | p 38 mitogen-activated kinases |
| RVMPI | right ventricular myocardial performance index |
| TAK, | 1Transforming growth factor beta-activated kinase 1 |
| TAPSE | tricuspid annular plane systolic excursion |
| TGF-β | transforming growth factor β |
| TNF-α | tumor necrosis factor -α |